A share price of Mannkind Corp [MNKD] is currently trading at $4.65, up 3.33%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MNKD shares have gain 29.89% over the last week, with a monthly amount glided 36.36%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 4, March 2024, MannKind Corporation Announces Participation at Upcoming Conferences. In a post published today on Yahoo Finance, MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it will be participating at upcoming conferences.
From an analyst’s perspective:
Mannkind Corp [NASDAQ: MNKD] stock has seen the most recent analyst activity on October 10, 2023, when Wedbush initiated its Outperform rating and assigned the stock a price target of $10. Previously, RBC Capital Mkts started tracking the stock with Sector Perform rating on May 14, 2021, and set its price target to $5. On December 24, 2019, Oppenheimer initiated with a Outperform rating and assigned a price target of $2.50 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $3 on October 25, 2019. BTIG Research initiated its recommendation with a Buy and recommended $3 as its price target on May 14, 2019. SVB Leerink started tracking with a Outperform rating for this stock on March 04, 2019, and assigned it a price target of $3. In a note dated February 22, 2019, SVB Leerink initiated an Outperform rating and provided a target price of $3 on this stock.
Mannkind Corp experienced fluctuations in its stock price throughout the past year between $3.17 and $5.75. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Mannkind Corp [NASDAQ: MNKD] shares were valued at $4.65 at the most recent close of the market. An investor can expect a potential return of 115.05% based on the average MNKD price forecast.
Analyzing the MNKD fundamentals
Trailing Twelve Months sales for Mannkind Corp [NASDAQ:MNKD] were 198.96M which represents 62.16% growth. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is 0.07 and Total Capital is 0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.52 points at the first support level, and at 4.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.73, and for the 2nd resistance point, it is at 4.80.
Mannkind Corp [MNKD] reported earnings per share of $0 for its fiscal quarter that ended on 12/30/2023. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.01 per share as compared to estimates of -$0.02 per share, a difference of $0.03 representing a surprise of 150.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Mannkind Corp [NASDAQ:MNKD] is 3.59. Also, the Quick Ratio is 3.31, while the Cash Ratio stands at 2.29. Considering the valuation of this stock, the price to sales ratio is 6.32.
Transactions by insiders
Recent insider trading involved Castagna Michael, Chief Executive Officer, that happened on Dec 15 when 90482.0 shares were sold. Chief Executive Officer, Castagna Michael completed a deal on Dec 14 to sell 0.11 million shares. Meanwhile, Chief Executive Officer Castagna Michael sold 10000.0 shares on Nov 01.
